These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25331234)

  • 1. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
    Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
    Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
    Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
    Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
    Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
    Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
    J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
    Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
    World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis.
    Ruiz-Gaspà S; Guañabens N; Jurado S; Combalia A; Peris P; Monegal A; Parés A
    Liver Int; 2020 Nov; 40(11):2767-2775. PubMed ID: 32749754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
    Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
    Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases.
    Jurado S; Parés A; Peris P; Combalia A; Monegal A; Guañabens N
    Bone; 2022 Sep; 162():116483. PubMed ID: 35787483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
    Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
    Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
    Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases.
    Ruiz-Gaspà S; Martinez-Ferrer A; Guañabens N; Dubreuil M; Peris P; Enjuanes A; Martinez de Osaba MJ; Alvarez L; Monegal A; Combalia A; Parés A
    Hepatology; 2011 Dec; 54(6):2104-13. PubMed ID: 21837749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
    Choi YH; Im EO; Suh H; Jin Y; Lee WH; Yoo YH; Kim KW; Kim ND
    Int J Oncol; 2001 May; 18(5):979-84. PubMed ID: 11295044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithocholic acid downregulates vitamin D effects in human osteoblasts.
    Ruiz-Gaspà S; Guañabens N; Enjuanes A; Peris P; Martinez-Ferrer A; de Osaba MJ; Gonzalez B; Alvarez L; Monegal A; Combalia A; Parés A
    Eur J Clin Invest; 2010 Jan; 40(1):25-34. PubMed ID: 20055894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
    J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
    Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
    BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
    Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
    J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling.
    Im E; Akare S; Powell A; Martinez JD
    Nutr Cancer; 2005; 51(1):110-6. PubMed ID: 15749637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
    Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
    J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.